Search alternatives:
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
latent decrease » latency decreased (Expand Search), content decreased (Expand Search), greatest decrease (Expand Search)
mean decrease » a decrease (Expand Search)
Showing 1,321 - 1,340 results of 48,433 for search '(( a ((mean decrease) OR (linear decrease)) ) OR ( a ((latent decrease) OR (largest decrease)) ))', query time: 0.97s Refine Results
  1. 1321
    Theoretical model.

    Theoretical model. by Jing-hua Yin (13007541)

    Published 2022
    Save to List
    Saved in:
  2. 1322
    Path analysis.

    Path analysis. by Jing-hua Yin (13007541)

    Published 2022
    Save to List
    Saved in:
  3. 1323
    Tumor volume decreases with increasing <i>Salmonella</i> dosage.

    Tumor volume decreases with increasing <i>Salmonella</i> dosage. by Robert A. Kazmierczak (3140379)

    Published 2016
    Save to List
    Saved in:
  4. 1324
    JTXK granule decreased the body weight and food intake in T2DM KKAy mice.

    JTXK granule decreased the body weight and food intake in T2DM KKAy mice. by Na Yu (151735)

    Published 2017
    Save to List
    Saved in:
  5. 1325
    Rapamycin treatment significantly decreases induction of lytic KSHV proteins.

    Rapamycin treatment significantly decreases induction of lytic KSHV proteins. by Lisa A. Nichols (357612)

    Published 2013
    Save to List
    Saved in:
  6. 1326
    Dexamethasone decreases PGC-1α protein expression and transcription.

    Dexamethasone decreases PGC-1α protein expression and transcription. by Jill A. Rahnert (2872766)

    Published 2016
    “…<p>(A) Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased PGC-1α protein expression (p = 0.01). n = 3/treatment from 3 experiments. …”
    Save to List
    Saved in:
  7. 1327
    Effect of decreased endogenous betaglycan expression on metanephric development and glomerulogenesis.

    Effect of decreased endogenous betaglycan expression on metanephric development and glomerulogenesis. by Kenneth A. Walker (280683)

    Published 2013
    Save to List
    Saved in:
  8. 1328
    Dexamethasone decreases CRTC1 and CRTC2 nuclear localization.

    Dexamethasone decreases CRTC1 and CRTC2 nuclear localization. by Jill A. Rahnert (2872766)

    Published 2016
    “…<p>Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased (A) total CRTC1 (p = 0.004 and CRTC2 protein (p = 0.0007). n = 9/treatment from 3 experiments. …”
    Save to List
    Saved in:
  9. 1329
    (Related to Fig 2A). Comparison of mean percentages of transfected cells with SGs calculated from three biological triplicates, showing the decrease in %, as compared to the control (pEGF-N3-transfected cells, “GFP”).

    (Related to Fig 2A). Comparison of mean percentages of transfected cells with SGs calculated from three biological triplicates, showing the decrease in %, as compared to the control (pEGF-N3-transfected cells, “GFP”). by Chiara Aloise (8374950)

    Published 2023
    Save to List
    Saved in:
  10. 1330
    Long-lived acceptor dark states can produce bimodal FRET efficiency distributions, multi-exponential donor excited-state decays, and a decrease in measured average FRET efficiency compared with that for the mean separation.

    Long-lived acceptor dark states can produce bimodal FRET efficiency distributions, multi-exponential donor excited-state decays, and a decrease in measured average FRET efficiency compared with that for the mean separation. by Steven S. Vogel (299330)

    Published 2013
    Save to List
    Saved in:
  11. 1331
    Percent accuracy and mean reaction time across the TLDB task.

    Percent accuracy and mean reaction time across the TLDB task. by David Apreutesei (19429483)

    Published 2024
    Save to List
    Saved in:
  12. 1332
    Mean body weight.

    Mean body weight. by Shane R. McClafferty (19434460)

    Published 2024
    Save to List
    Saved in:
  13. 1333
    Main parameters and meanings.

    Main parameters and meanings. by Tiaojuan Han (18196471)

    Published 2024
    Save to List
    Saved in:
  14. 1334
    Intrathecal delivery of IL-6 increases cAMP and AC levels and decreases PDE level in the sensorimotor cortex.

    Intrathecal delivery of IL-6 increases cAMP and AC levels and decreases PDE level in the sensorimotor cortex. by Ping Yang (56755)

    Published 2015
    “…<p>Seven days after intrathecal delivery of IL-6, IL-6 and AG-490, or saline, cAMP, AC and PDE levels in the sensorimotor cortex were determined by ELISA. cAMP (A) and AC (C) levels increased while PDE (B) level decreased in IL-6 delivery group compared with that of saline group. …”
    Save to List
    Saved in:
  15. 1335
    Study Flow Diagram.

    Study Flow Diagram. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  16. 1336
    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90.

    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  17. 1337
    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments).

    Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  18. 1338
    Antibody and antigen responses to Ensovibep vs placebo day 1–90.

    Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  19. 1339
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  20. 1340
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:

Search Tools: